The U.S. Food and Drug Administration confirmed today that a meeting of its independent advisory panel to discuss the composition of this year’s flu vaccine had been canceled and that the regulator would instead make recommendations later.
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13. Committee members received an email informing them of the cancellation Wednesday afternoon with no rescheduling information and no reason given for the cancellation,
A meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters, the second such disruption to a federal vaccine advisory panel since Robert F.
The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza vaccines, an HHS official confirmed Thursday.
A Food and Drug Administration vaccine advisory committee meeting that was set to discuss what flu strains to include in next season's flu vaccine has been canceled, multiple sources told ABC News, leaving some to wonder if the meeting cancelation will delay next year's flu vaccine delivery schedule.
Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health agencies under Robert F. Kennedy Jr.’s leadership.
President Donald Trump's administration has canceled a meeting to decide the makeup of next winter's flu vaccine.On Wednesday, The Washington Post reported that the Food and Drug Administration had informed the Vaccines and Related Biological Products Advisory Committee via email that the meeting had been canceled.
The Food and Drug Administration has canceled an annual advisers meeting to weigh in on yearly updates to the flu vaccine, raising some experts' concerns about next year's shot. CBS News chief medical correspondent Dr.
The Food and Drug Administration abruptly canceled a critical meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), which gathers annually in March to determine what flu strains will be covered by next year’s vaccine.